Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.65 |
| ▸ | MAPT | P10636 | 1/20 | 0.65 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | STS | P08842 | 1/20 | 0.53 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.53 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 3/20 | 0.51 |
| ▸ | RAB9A | P51151 | 3/20 | 0.51 |
| ▸ | PLAU | P00749 | 2/20 | 0.50 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | PLK1 | P53350 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3919749 | 0.94 | MAPT (0.56) | L3MBTL1MAPTSRD5A2ALDH1A1TP53 | |
| SCHEMBL12566040 | 0.92 | ALDH1A1 (0.61) | L3MBTL1MAPTSRD5A2ALDH1A1NPC1 | |
| SCHEMBL7129800 | 0.88 | MAPT (0.80) | L3MBTL1MAPTSRD5A2STSS1PR5 | |
| SCHEMBL12065143 | 0.85 | L3MBTL1 (0.62) | L3MBTL1MAPTSRD5A2ALDH1A1STS | |
| Butane SCHEMBL4453322 | 0.84 | MAPT (0.63) | L3MBTL1MAPTSRD5A2ALDH1A1STS | |
| SCHEMBL11635179 | 0.84 | L3MBTL1 (0.69) | L3MBTL1MAPTSRD5A2STSS1PR5 | |
| Alcohol SCHEMBL11084219 | 0.84 | MAPT (0.63) | L3MBTL1MAPTSRD5A2ALDH1A1STS | |
| Methyl Alcohol SCHEMBL11602292 | 0.84 | MAPT (0.68) | L3MBTL1MAPTSRD5A2ALDH1A1STS | |
| SCHEMBL7199268 | 0.83 | MAPT (0.67) | L3MBTL1MAPTSRD5A2ALDH1A1STS | |
| SCHEMBL24800 | 0.83 | MAPT (0.73) | L3MBTL1MAPTSRD5A2ALDH1A1STS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113755862-B | Method for preparing aromatic alpha-diketone compound by electrochemical oxidation | 西南大学 | 2022-08-19 | — | — | CN | claimed |
| CN-113755862-A | Method for preparing aromatic alpha-diketone compound by electrochemical oxidation | 西南大学 | 2021-12-07 | — | — | CN | claimed |
| CN-118908819-B | Preparation method of organic ketone compound under synergistic catalysis of light and metal | 延安大学 | 2025-04-18 | — | — | CN | disclosed |
| CN-118908819-A | Preparation method of organic ketone compound under synergistic catalysis of light and metal | 延安大学 | 2024-11-08 | — | — | CN | disclosed |
| CN-113755862-B | Method for preparing aromatic alpha-diketone compound by electrochemical oxidation | 西南大学 | 2022-08-19 | — | — | CN | disclosed |
| CN-113755862-A | Method for preparing aromatic alpha-diketone compound by electrochemical oxidation | 西南大学 | 2021-12-07 | — | — | CN | disclosed |
| CN-106547168-B | Black matrix material composition and application | 深圳市华星光电技术有限公司 | 2020-09-01 | — | — | CN | disclosed |
| US-8293715-B2 | 10a-Azalide compound crosslinked at 10a- and 12-positions | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2012-10-23 | — | — | US | disclosed |
| US-20110237784-A1 | 10A-AZALIDE COMPOUND CROSSLINKED AT 10A- AND 12-POSITIONS | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2011-09-29 | — | — | US | disclosed |
| EP-0423524-A2 | Propiophenone derivatives and their preparation and pharmaceutical use | MARUHO Co., Ltd. (JP) | 1991-04-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110237784-A1 | 10A-AZALIDE COMPOUND CROSSLINKED AT 10A- AND 12-POSITIONS | DCLRE1A, AZI2, CHD9 | L3MBTL1 2750/4885MAPT 4511/4885SRD5A2 1549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.